Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences - PubMed (original) (raw)
Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences
Hannah J Jones et al. JAMA Psychiatry. 2018.
Abstract
Importance: There is concern about potentially causal effects of tobacco use on psychosis, but epidemiological studies have been less robust in attempts to minimize effects of confounding than studies of cannabis use have been.
Objectives: To examine the association of patterns of cigarette and cannabis use with preceding and subsequent psychotic experiences, and to compare effects of confounding across these patterns.
Design, setting, and participants: This cohort study used data from the Avon Longitudinal Study of Parents and Children, which initially consisted of 14 062 children. Data were collected periodically from September 6, 1990, with collection ongoing, and analyzed from August 8, 2016, through June 14, 2017. Cigarette and cannabis use data were summarized using longitudinal latent class analysis to identify longitudinal classes of substance use. Associations between classes and psychotic experiences at age 18 years were assessed.
Exposures: Depending on the analysis model, exposures were longitudinal classes of substance use or psychotic experiences at age 12 years.
Main outcomes and measures: Logistic regression was used to examine the associations between substance use longitudinal classes and subsequent onset of psychotic experiences.
Results: Longitudinal classes were derived using 5300 participants (56.1% female) who had at least 3 measures of cigarette and cannabis use from ages 14 to 19 years. Prior to adjusting for a range of potential confounders, there was strong evdience that early-onset cigarette-only use (4.3%), early-onset cannabis use (3.2%), and late-onset cannabis use (11.9%) (but not later-onset cigarette-only use [14.8%]) latent classes were associated with increased psychotic experiences compared with nonusers (65.9%) (omnibus P < .001). After adjusting for confounders, the association for early-onset cigarette-only use attenuated substantially (unadjusted odds ratio [OR], 3.03; 95% CI, 1.13-8.14; adjusted OR, 1.78; 95% CI, 0.54-5.88), whereas those for early-onset cannabis use (adjusted OR, 3.70; 95% CI, 1.66-8.25) and late-onset cannabis use (adjusted OR, 2.97; 95% CI, 1.63-5.40) remained consistent.
Conclusions and relevance: In this study, our findings indicate that while individuals who use cannabis or cigarettes during adolescence have an increased risk of subsequent psychotic experiences, epidemiological evidence is substantively more robust for cannabis use than it is for tobacco use.
Conflict of interest statement
Conflict of Interest Disclosures: None reported.
Figures
Figure.. Five-Class Model of Cigarette and Cannabis Use Patterns From a Sample of 5300 Participants
The probability axis represents the probability of a class member being a nonuser, a cigarette-only user, or a cannabis with or without cigarette user at each time point.
References
- Moore THM, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328. - PubMed
- Sørensen HJ, Mortensen EL, Reinisch JM, Mednick SA. A prospective study of smoking in young women and risk of later psychiatric hospitalization. Nord J Psychiatry. 2011;65(1):3-8. - PubMed
Publication types
MeSH terms
Grants and funding
- MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom
- MC_UU_00011/7/MRC_/Medical Research Council/United Kingdom
- MR/K023195/1/MRC_/Medical Research Council/United Kingdom
- G0701503/MRC_/Medical Research Council/United Kingdom
- MR/K023233/1/MRC_/Medical Research Council/United Kingdom
- MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom
- G0802736/MRC_/Medical Research Council/United Kingdom
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- MR/M006727/1/MRC_/Medical Research Council/United Kingdom
- MC_PC_15018/MRC_/Medical Research Council/United Kingdom
- MR/L022206/1/MRC_/Medical Research Council/United Kingdom
- G0801418/MRC_/Medical Research Council/United Kingdom
- G0800612/MRC_/Medical Research Council/United Kingdom
- G9815508/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical